Biogen Inc (BIIB)

148.25 +1.78 (+1.22%) USD  |  NASDAQ  |  Dec 23, 10:55
More

Biogen Cash and Short Term Investments (Quarterly): 1.699B for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for BIIB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Eli Lilly and Co 3.518B
Pfizer Inc 9.952B
Regeneron Pharmaceuticals Inc 9.796B
Sage Therapeutics Inc 569.15M
Moderna Inc 6.867B